Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 21 Sept 2023 for Paratek Pharmaceuticals, Inc., €80k. Read the official filing
Filing timeline
BuySaleMichael Bigham
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Bigham: trading record in brief
Michael Bigham is a declared insider at 2 companies (chief executive); the most frequent names are Paratek Pharmaceuticals, Inc. and Adamas Pharmaceuticals Inc. We count 14 filings; the first trade dates from 4 February 2016 and the latest from 8 August 2023.
Sales make up the whole of the open-market record (3 sales, €77k). Besides market trades, the filings include 9 share grants and 1 option exercise.
The latest filing, published on 21 September 2023, reports an option exercise of €80k in Paratek Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Bigham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
23,255 shares@ US$4.3045.2% of flowCommon StockSEC:0000899243-23-019356:0
156,250 shares0Common StockSEC:0000904454-23-000476:0
45,000 shares0Common StockSEC:0000904454-22-000647:0
19,484 shares@ US$1.9820.7% of flowCommon StockSEC:0000904454-22-000621:0
6,000 shares@ US$3.4711.8% of flowCommon StockSEC:0000904454-22-000526:0
30,000 shares0Common StockSEC:0000904454-22-000504:0
143,182 shares0Common StockSEC:0000904454-22-000423:0
202,500 shares0Common StockSEC:0000904454-22-000262:0
5,059 shares@ US$4.4225.6% of flowCommon StockSEC:0000904454-21-000846:0
10,000 sharesCommon StockSEC:0001328143-21-000095:0
75,000 shares0Common StockSEC:0000904454-21-000626:0
85,909 shares0Common StockSEC:0000904454-21-000514:0
5,000 shares0Common StockSEC:0001328143-21-000054:0
30,000 sharesCommon StockSEC:0000904454-16-000934:0
14 of 14 declarations
